Radiation oncology outpatients' patterns of life expectancy discussions.
communication
end of life
life expectancy
patient-centred care
Journal
European journal of cancer care
ISSN: 1365-2354
Titre abrégé: Eur J Cancer Care (Engl)
Pays: England
ID NLM: 9301979
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
05
10
2017
revised:
07
01
2019
accepted:
17
01
2019
pubmed:
20
2
2019
medline:
25
1
2020
entrez:
20
2
2019
Statut:
ppublish
Résumé
To describe the (a) number and type of cancer care providers that radiation oncology outpatients report discussing life expectancy with, and (b) perceptions of the acceptability and utility of life expectancy information. A cross-sectional survey of patients receiving radiotherapy was undertaken in four treatment centres. Patients indicated whether they had discussed life expectancy with a cancer doctor (i.e., medical oncologists, radiation oncologists, surgeon, haematologists) and/or other cancer care provider (i.e., general practitioner, radiation therapist, nurse); and acceptability and utility of information. Of 207 respondents, 133 (64%) had discussed life expectancy with at least one provider. General practitioners (GPs) were the most frequent source of information. Of those who had discussed life expectancy, half (n = 110/207) perceived cancer would not impact life expectancy. Information was easy to understand (91%), discussed sensitively (90%), helped plan for future (83%) and gave them certainty (86%). The information made 11% feel overloaded and 34% feel anxious. Two-thirds of respondents had discussed life expectancy with at least one cancer care provider. Providers from the range of disciplines involved in cancer care need to be skilled at communicating life expectancy information and recognising the adverse impact this may have on some patients.
Types de publication
Journal Article
Langues
eng
Pagination
e13021Subventions
Organisme : The Cancer Council NSW
Organisme : Australian Research Council
Organisme : Australian National Breast Cancer Foundation
Organisme : National Health and Medical Research Council
Informations de copyright
© 2019 John Wiley & Sons Ltd.